Mosby's Drug Reference

Over 5,000 Drug Listings

Free · In-App Purchases

*Try Free for 14 Days* Updated with 2025 content, including dozens of new medications. Access 5,000+ drugs, patient safety alerts, notes, highlights, and favorites. 14-Day Free Trial ** Trusted by Health Care Professionals for Over 30 Years ** ABOUT MOSBY’S DRUG REFERENCE Based on the latest edition, Mosby's Drug Reference provides health care professionals with the tools they need to eliminate errors and improve accuracy. Drug monographs feature concise, easy-to-understand information and make finding answers easy with sections on each drug's action, usage, dosage, interactions, side effects, and more. With an emphasis on patient safety, this best-selling app includes Black Box Warnings for dangerous adverse reactions, Safety Alerts for situations requiring special attention, and a focus on life-threatening side effects of 50 common drug classes. FEATURES • More than 5,000 generic and trade-name drugs are profiled • Appendix of recent FDA-approvals • Icons for High Alert and Rarely Used medications • Highlighted Black Box Warnings, safety alerts, and life-threatening side effects • Helpful IV therapy updates • Create custom notes and highlights within entries • 150+ abbreviations listed for practical understanding • Unlabeled uses and help with easily confused drug names • Full Text Search helps find medications quickly • “Favorites” for bookmarking important entries FREE 14-DAY TRIAL: WHAT TO EXPECT • First-time users can access Unbound's complete Mosby's Drug Reference mobile app free for 14 days • After 14 days, your iTunes account will be charged $45.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends. • To manage your subscriptions, open Apple's “Settings” app and tap on the “iTunes & App Store" entry. Tap your Apple ID at the top of the screen and login. Tap subscriptions, then tap the subscription you wish to manage. •NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period. iTunes automatic renewal: Your subscription automatically renews unless auto-renew is turned off 24 hours prior to the conclusion of your current period. Auto Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase. Your iTunes account will automatically be charged the current renewal rate ($45.99) within 24 hours prior to the end of the subscription period. If you choose not to renew, you will be able to use the app, however will not receive updates. Authors: Linda Skidmore-Roth, RN, MSN, NP Publisher: Elsevier Powered by: Unbound Medicine Unbound Privacy Policy: www.unboundmedicine.com/privacy Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement

  • This app hasn’t received enough ratings or reviews to display an overview.

Updated the app information to be in compliance with the latest regulatory changes.

The developer, Unbound Medicine, Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .

  • Data Linked to You

    The following data may be collected and linked to your identity:

    • Contact Info
    • Search History
    • Identifiers
    • Usage Data

Privacy practices may vary, for example, based on the features you use or your age. Learn More

The developer has not yet indicated which accessibility features this app supports. Learn More

  • Seller
    • Unbound Medicine, Inc.
  • Size
    • 9.8 MB
  • Category
    • Medical
  • Compatibility
    Requires iOS 14.0 or later.
    • iPhone
      Requires iOS 14.0 or later.
    • iPad
      Requires iPadOS 14.0 or later.
    • iPod touch
      Requires iOS 14.0 or later.
    • Mac
      Requires macOS 11.0 or later.
    • Apple Vision
      Requires visionOS 1.0 or later.
  • Languages
    • English
  • Age Classification
    16+
  • In-App Purchases
    Yes
  • Copyright
    • © 2025 Unbound Medicine, Inc.